DYAI - Dyadic to Present at Industry Events in November | Benzinga
JUPITER, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be participating and presenting at the following industry events during the month of November:
Cultured Meat Symposium 2023, November 2-3, 2023
StarBase, Las Vegas
Joseph Hazelton, Chief Business Officer
8th International Vaccines Research & Development, November 6-8, 2023
Hilton Baltimore BWI Airport Hotel, Linthicum Heights, MD
Mark Emalfarb, President, and Chief Executive Officer
"Next-Gen Vaccines without the Right Platform Limit Pandemic Effectiveness C1, Protective, Rapid, High Yield, Low-Cost Global Solution"
Presentation Time: Monday, November 6, 2023, 2:10 PM – 2:30 PM ET
BARDA Industry Day 2023, November 13-14, 2023
Grand Hyatt Washington, Washington, DC
Joseph Hazelton, Chief Business Officer
Vaccines Summit, November 13-15, 2023
Sheraton Boston Needham Hotel, Boston, MA
Mark Emalfarb, President, and Chief Executive Officer
"Rapid development and flexible scale of complex recombinant proteins and antigens including ferritin nanoparticles for infectious ...